(Q38236887)

31 August 2017

title

Fracture mortality: associations with epidemiology and osteoporosis treatment (English)

1 reference

31 August 2017

0 references

1 reference

Sebastian E Sattui

1

1 reference

31 August 2017

Kenneth G Saag

series ordinal

2

1 reference

31 August 2017

publication date

5 August 2014

1 reference

Nature Reviews Endocrinology

31 August 2017

published in

1 reference

31 August 2017

volume

10

1 reference

31 August 2017

issue

10

1 reference

31 August 2017

page(s)

592-602

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2014.125

31 August 2017

exact match

0 references

cites work

Non-trauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Bone mineral density is a predictor of survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Rate of bone loss is associated with mortality in older women: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Bone mineral density and all-cause, cardiovascular and stroke mortality: a meta-analysis of prospective cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Excess mortality following hip fracture: a systematic epidemiological review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Risk of subsequent fracture and mortality within 5 years after a non-vertebral fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Factors associated with mortality and functional disability after hip fracture: an inception cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Hip fracture and increased short-term but not long-term mortality in healthy older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Mortality after all major types of osteoporotic fracture in men and women: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Association between vertebral fracture and increased mortality in osteoporotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

The effect of vertebral fracture as a risk factor for osteoporotic fracture and mortality in a Spanish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Mortality rates after incident non-traumatic fractures in older men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Mortality following fractures in older women. The study of osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Epidemiology and outcomes of osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Zoledronic acid and clinical fractures and mortality after hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Osteoporosis medication and reduced mortality risk in elderly women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Mortality and morbidity associated with osteoporosis drug treatment following hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Secondary prevention of hip fractures among the hospitalized elderly: are we doing enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Do patients receive recommended treatment of osteoporosis following hip fracture in primary care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Evidence summary: systematic review of surgical treatments for geriatric hip fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Hip fracture protocols: what have we changed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Preoperative predictors for mortality following hip fracture surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Timing matters in hip fracture surgery: patients operated within 48 hours have better outcomes. A meta-analysis and meta-regression of over 190,000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

An estimate of the worldwide prevalence and disability associated with osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Hip fractures in institutionalized elderly people: incidence rates and excess mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Excess mortality following hip fracture: the role of underlying health status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Mortality and mobility after hip fracture in Japan: a ten-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Meta-analysis: excess mortality after hip fracture among older women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Hip fracture and risk of acute myocardial infarction: a nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Incidence and mortality of hip fractures in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Risk-adjusted mortality rates of elderly veterans with hip fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Gender differences in epidemiology and outcome after hip fracture: evidence from the Scottish Hip Fracture Audit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Amount of social contact and hip fracture mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

The association of race, gender, and comorbidity with mortality and function after hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Patterns of rehabilitation utilization after hip fracture in acute hospitals and skilled nursing facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Risk of mortality following hip fracture in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Mortality risk after hip fracture. 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Quality of life, morbidity, and mortality after low trauma hip fracture in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Survival and functional outcome according to hip fracture type: a one-year prospective cohort study in elderly women with an intertrochanteric or femoral neck fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Hospitalised osteoporotic vertebral fractures in Spain: analysis of the national hospital discharge registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Long-term morbidity and mortality after a clinically diagnosed vertebral fracture in the elderly--a 12- and 22-year follow-up of 257 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Mortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Five-year outcome of individuals with hip fracture admitted to a Singapore hospital: quality of life and survival rates after treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Mortality following the diagnosis of a vertebral compression fracture in the Medicare population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: a long-term prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Mortality after vertebral fracture in Korea: analysis of the National Claim Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Incident vertebral fractures and mortality in older women: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Is radiographic vertebral fracture a risk factor for mortality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Long-term mortality following fractures at different skeletal sites: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Effect of osteoporosis treatment on mortality: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients-a nationwide register-based open cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Potential mediators of the mortality reduction with zoledronic acid after hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Cytokines and C-reactive protein production in hip-fracture-operated elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Association between interleukin-6 and lower extremity function after hip fracture--the role of muscle mass and strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Elevation of plasma CGRP and SP levels in orthopedic patients with fracture neck of femur.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Volumetric and areal bone mineral density measures are associated with cardiovascular disease in older men and women: the health, aging, and body composition study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Effects of bisphosphonates on prostaglandin E2 and thromboxane B2 production in human whole blood and monocytes stimulated by lipopolysaccharide and A23187

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Bisphosphonates reduced the risk of acute myocardial infarction: a 2-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Bisphosphonates stimulate an endogenous nonselective cation channel in Xenopus oocytes: potential mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Physiological and morphological effects of alendronate on rabbit esophageal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Myocardial infarction risk among patients with fractures receiving bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Incidence and mortality of hip fracture among the elderly population in South Korea: a population-based study using the national health insurance claims data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Factors associated with mortality following hip fracture in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Race and sex differences in mortality following fracture of the hip

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Risk of Mortality Following Clinical Fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

What Proportion of Incident Radiographic Vertebral Deformities Is Clinically Diagnosed and Vice Versa?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Mortality after osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Effect of Hip Fracture on Mortality in Elderly Women: The EPIDOS Prospective Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Excess mortality after hospitalisation for vertebral fracture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Population-based study of survival after osteoporotic fractures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

The components of excess mortality after hip fracture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Oral bisphosphonates are associated with reduced mortality after hip fracture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Surgical management of hip fractures: an evidence-based review of the literature. I: femoral neck fractures.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

The effect of hip fracture on mortality, hospitalization, and functional status: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Excess mortality attributable to hip fracture in white women aged 70 years and older

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Gender differences in mortality after hip fracture: the role of infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Survival after hip fracture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Survival after hip fracture: short- and long-term excess mortality according to age and gender

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Relative survival after hospitalisation for hip fracture in older people in New South Wales, Australia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Rehabilitation after hip fracture--equal opportunity for all?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Morbidity and mortality for elderly patients with fractured neck of femur treated by hemiarthroplasty

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Age and sex as determinants of mortality after hip fracture: 3,895 patients followed for 2.5-18.5 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Predictors of mortality after hip fracture: results from 1-year follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Intertrochanteric versus femoral neck hip fractures: differential characteristics, treatment, and sequelae

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Mortality rates of patients with a hip fracture in a southwestern district of Greece: ten-year follow-up with reference to the type of fracture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

The prevalence of osteoporosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Recognition of vertebral fracture in a clinical setting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Transmission of human herpesvirus 8 by blood transfusion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Vascular endothelial growth factor (VEGF) in plasma increases after hip surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Bisphosphonates may retrieve endothelial function in vascular diseases similar to statins' effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Mortality risk for operated and nonoperated vertebral fracture patients in the medicare population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.125

Determinants of reduced survival following hip fractures in men.

31 March 2020

1 reference

12 December 2020

Mortality and osteoporotic fractures: is the link causal, and is it modifiable?

1 reference

12 December 2020

Hip fracture causes excess mortality owing to cardiovascular and infectious disease in institutionalized older people: a prospective 5-year study

1 reference

12 December 2020

Predictors of mortality after hip fracture: a 10-year prospective study.

1 reference

12 December 2020

Hip fracture incidence and mortality in New England

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2014.125

1 reference

Dimensions Publication ID

31 August 2017

1004508818

0 references

1 reference